References
Wykrzykowska J, Lehman S, Williams G, et al.: Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009, 50:563–568.
Rudd JH, Narula J, Strauss HW, et al.: Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol 2010, 55:2527–2535.
Fox JJ, Strauss HW: One step closer to imaging vulnerable plaque in the coronary arteries. J Nucl Med 2009, 50:497–500.
Hyafil F, Cornily JC, Rudd JH, et al.: Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. J Nucl Med 2009, 50:959–965.
Jaffer FA, Libby P, Weissleder R: Molecular imaging of cardiovascular disease. Circulation 2007, 116:1052–1061.
Acknowledgment
AHA Scientist Development Award (#0830352N) and the Howard Hughes Medical Institute Early Career Award, NIH RO1-HL108229.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hucker, W.J., Jaffer, F.A. 18F-FDG PET Imaging of Atherosclerosis—A New Approach to Detect Inflamed, High-Risk Coronary Plaques?. Curr Cardiovasc Imaging Rep 4, 1–3 (2011). https://doi.org/10.1007/s12410-010-9054-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12410-010-9054-4